Reporting owner · CIK 0001946439
Davis Krista
Visual SEC Form 4 history across 1 companies, 15 transactions and 9 filings.
SVP, CHOSVP, CHIEF HR OFFICERANI PHARMACEUTICALS INC
Open-market mix
0%buys
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #55732 | ANIP | Davis Krista | SVPCHO | sale10b5-1 | 5.08k | -$37.7M | S | 03/10 | 03/09 |
| #55731 | ANIP | Davis Krista | SVPCHO | sale10b5-1 | 1.48k | -$11.1M | S | 03/10 | 03/06 |
| #55602 | ANIP | Davis Krista | SVPCHO | withholding | 1.55k | -$11.4M | F | 03/02 | 02/28 |
| #55601 | ANIP | Davis Krista | SVPCHO | grant | 10.8k | $83.3M | A | 03/02 | 02/26 |
| #55432 | ANIP | Davis Krista | SVPCHO | sale10b5-1 | 1.73k | -$13.4M | S | 02/23 | 02/20 |
| #55430 | ANIP | Davis Krista | SVPCHO | sale10b5-1 | 2.08k | -$16.1M | S | 02/23 | 02/19 |
| #55398 | ANIP | Davis Krista | SVPCHO | withholding | 1.29k | -$9.97M | F | 02/17 | 02/14 |
| #55397 | ANIP | Davis Krista | SVPCHO | withholding | 1.18k | -$9.05M | F | 02/17 | 02/12 |
| #72565 | ANIP | Davis Krista | SVPCHO | withholding | 3.01k | -$23.0M | F | 02/13 | 02/11 |
| #198834 | ANIP | Davis Krista | SVPCHO | sale10b5-1 | 1.00k | -$6.08M | S | 03/11/2025 | 03/07/2025 |
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at ANI PHARMACEUTICALS INC on Mar 09, 2026 valued at $377,099.
Review SEC filingLatest buy
No open-market insider purchase is available.
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
15 observations · Feb 12, 2025 – Mar 9, 2026. Window ends at the latest available report, not today.
Selected observation · Mar 9, 202651,946 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Feb 12, 2025 | 62,116 | Feb 19, 2025 | View transaction |
| Feb 12, 2025 | 70,820 | Feb 19, 2025 | View transaction |
| Feb 14, 2025 | 69,624 | Feb 19, 2025 | View transaction |
| Feb 21, 2025 | 68,624 | Feb 24, 2025 | View transaction |
| Feb 28, 2025 | 67,525 | Mar 4, 2025 | View transaction |
| Mar 7, 2025 | 66,525 | Mar 11, 2025 | View transaction |
| Feb 11, 2026 | 55,547 | Feb 13, 2026 | View transaction |
| Feb 12, 2026 | 54,367 | Feb 17, 2026 | View transaction |
| Feb 14, 2026 | 53,077 | Feb 17, 2026 | View transaction |
| Feb 19, 2026 | 50,993 | Feb 23, 2026 | View transaction |
| Feb 20, 2026 | 49,263 | Feb 23, 2026 | View transaction |
| Feb 26, 2026 | 60,073 | Mar 2, 2026 | View transaction |
| Feb 28, 2026 | 58,518 | Mar 2, 2026 | View transaction |
| Mar 6, 2026 | 57,033 | Mar 10, 2026 | View transaction |
| Mar 9, 2026 | 51,946 | Mar 10, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Feb 25
−$60.2K
Mar 25
−$60.9K
Feb 26
−$296.5K
Mar 26
−$488.5K
Transaction texture
Ownership and ticket size
Average P/S size$151K
Median P/S size$123.1K
Direct15
Indirect0
Mar 09, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Visual map of known reporting history
Davis Krista Insider Activity FAQ
SEC Form 4 context
Who is Davis Krista?
Davis Krista is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001946439.
Which companies has Davis Krista reported transactions for?
ANI PHARMACEUTICALS INC
When was Davis Krista's latest insider buy?
No open-market insider purchase is available for this period.
When was Davis Krista's latest insider sale?
sale at ANI PHARMACEUTICALS INC on Mar 09, 2026 valued at $377,099.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.